Cigna Group $CI Shares Sold by Aberdeen Group plc

Aberdeen Group plc lowered its position in shares of Cigna Group (NYSE:CI) by 5.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 223,757 shares of the health services provider’s stock after selling 13,883 shares during the period. Aberdeen Group plc owned approximately 0.08% of Cigna Group worth $64,765,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Cigna Group by 11.7% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock valued at $13,039,000 after purchasing an additional 4,738 shares in the last quarter. Maj Invest Holding A S increased its stake in Cigna Group by 2.4% during the 3rd quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock valued at $121,854,000 after buying an additional 10,042 shares during the period. Providence Capital Advisors LLC increased its stake in Cigna Group by 1,016.8% during the 3rd quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock valued at $2,453,000 after buying an additional 7,748 shares during the period. National Pension Service raised its position in shares of Cigna Group by 3.2% during the 3rd quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock worth $197,091,000 after buying an additional 21,203 shares in the last quarter. Finally, SCS Capital Management LLC lifted its stake in shares of Cigna Group by 39.1% in the 2nd quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock worth $10,127,000 after acquiring an additional 8,609 shares during the period. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Stock Performance

Shares of NYSE CI opened at $291.35 on Monday. The stock’s fifty day simple moving average is $276.85 and its 200 day simple moving average is $283.57. The stock has a market capitalization of $77.83 billion, a price-to-earnings ratio of 13.14, a PEG ratio of 1.01 and a beta of 0.27. The company has a quick ratio of 0.76, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.Cigna Group’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter last year, the company posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, sell-side analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be given a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. Cigna Group’s payout ratio is 27.23%.

Analyst Ratings Changes

CI has been the topic of a number of research analyst reports. Barclays lowered their price objective on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a research note on Friday, February 6th. Royal Bank Of Canada lowered their price target on Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a research report on Friday, February 6th. Robert W. Baird cut their price objective on Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a report on Thursday, December 11th. Deutsche Bank Aktiengesellschaft raised their target price on Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research note on Tuesday, February 10th. Finally, UBS Group reiterated a “buy” rating and issued a $375.00 price target on shares of Cigna Group in a research report on Monday, February 9th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $330.00.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.